Filing Details
- Accession Number:
- 0001415889-24-029742
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-12-18 16:35:07
- Reporting Period:
- 2024-12-16
- Accepted Time:
- 2024-12-18 16:35:07
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1231457 | Genelux Corp | GNLX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1939198 | Joseph Cappello | C/O Genelux Corporation 2625 Townsgate Road, Suite 230 Westlake Village CA 91361 | Vp, Pharmaceutical Development | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2024-12-16 | 6,300 | $2.34 | 14,653 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Represents shares sold by the Reporting Person to cover estimated taxes to be paid by the Reporting Person in connection with the vesting of restricted stock units.
Billionaire Hedge Funds
